Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferumoxytol Nanozymes for Biofilm Disruption in Endodontic Treatment
NCT07518901Phase 4Enrolling by invitation
- Sponsor
- University of Pennsylvania
- Start
- Aug 2026
- Primary completion
- Jun 2028
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ferumoxytol in apical periodontitis (AP), Endodontic infection, endodontic disease, sponsored by University of Pennsylvania. Started Aug 2026; status: enrolling by invitation.
02
Drugs
ferumoxytol
03
Conditions
apical periodontitis (AP)Endodontic infectionendodontic disease
Beyond the preview
Go deeper on NCT07518901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07518901.